Magang Shou

Title: Innovator Spotlight: Magang Shou and His Contributions

Introduction: Magang Shou, based in Maple Glen, Pennsylvania, is an esteemed inventor known for his significant contributions to the field of biotechnology. His innovative work focuses on developing antibodies, which have crucial applications in pharmacogenomics.

Latest Patents: Magang holds a prominent patent titled "Antibodies for human cytochrome P450 2D6." This invention features antibodies known as 'MAb50-4' and 'MAb184-10', along with polypeptides that compete for binding to the cytochrome P450 enzyme CYP2D6. Notably, MAb50-4 can be produced using the ATCC reference number PTA-3489, while MAb184-10 can be derived from ATCC No. PTA-1999.

Career Highlights: Magang Shou is affiliated with Merck & Company, Inc., where he has contributed to various research initiatives and developments in biopharmaceuticals. His expertise in antibody development and understanding of cytochrome P450 enzymes has been a testament to his role in advancing medical therapies.

Collaborations: Throughout his career, Magang has collaborated with fellow researchers, including his coworker Qin Mei. Together, they have explored innovative solutions to enhance drug efficacy and safety through targeted antibody therapies.

Conclusion: Magang Shou's inventive spirit and dedication to biotechnology have led to remarkable advancements in the field. His patent on antibodies for human cytochrome P450 2D6 exemplifies the impact of research and innovation on healthcare and medicine. As he continues his work at Merck & Company, Inc., it will be exciting to observe the future contributions he will make to science.